San Diego, CA, United States of America

Stephen P Schoenberger

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Stephen P Schoenberger

Introduction

Stephen P Schoenberger is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of immunology, particularly in the identification of neoantigens. His work focuses on developing systems and methods that enhance the capabilities of engineered immune cells to target specific cancer-related peptides.

Latest Patents

One of Schoenberger's notable patents is titled "Methods of neoantigen identification." This patent describes systems and methods for identifying neoantigen peptide candidates. These innovative systems can be utilized to generate engineered immune cells that specifically target neoantigen peptides. Importantly, the methods outlined in the patent do not require in silico epitope binding prediction algorithms. Additionally, the systems can identify neoantigens for cancers or tumors that exhibit a low mutational burden. Schoenberger holds 1 patent in this area.

Career Highlights

Throughout his career, Stephen P Schoenberger has been at the forefront of research in immunology. His work has contributed to a deeper understanding of how the immune system can be harnessed to combat cancer. His innovative approaches have paved the way for new therapeutic strategies that could significantly improve patient outcomes.

Collaborations

Schoenberger has collaborated with notable researchers in the field, including Bjoern Peters and Alessandro Sette. These collaborations have further enhanced the impact of his work and have contributed to advancements in the identification and targeting of neoantigens.

Conclusion

In summary, Stephen P Schoenberger is an influential inventor whose work in neoantigen identification has the potential to revolutionize cancer treatment. His innovative methods and collaborative efforts continue to push the boundaries of immunological research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…